Top Five Ways Study Sites Benefit from Remote Monitoring

Failed remote site access and clinical trial monitoring attempts have left sites with a computer full of site portals, FTP logins, document vaults, and emails.

Why do sponsor remote site access and monitoring rollouts fail? Because the sponsor focuses on solving their site access problems – not the workflow challenges of the sites.

The rapid rise of the Electronic Investigator Site File (eISF) as the foundation for remote site access solves this problem by providing equal benefit to the site and the sponsor – driving adoption and success across clinical trial stakeholders.

This centralization of documents, workflows, and processes provided sponsors a single point of access to the study site. While the benefits of remote site access for sponsors are clear, sites too now have a valuable tool at their disposal that provides five key benefits.

You can take action now:

The benefits of remote site monitoring to the study site have been murky at best over the last decade. Now, though, study sites are finding significant value in moving their internal operations to an eISF + Remote Site Access platform, as is evident in the 10,000 study sites on our platform.

Site leadership, you have an opportunity to invest in an eISF platform now to:

  • Be “in the driver’s seat” of how you will collaborate remotely with sponsors and CROs.
  • Optimize internal workflows across studies and sites.
  • Be a preferred study site partner for sponsors and CROs requiring remote site access.

Sponsor clinical operations leaders, you have an opportunity now to accelerate operations with remote site access through a platform that solves site workflow challenges: ensuring adoption and long-term success.

If you do not have an eISF + Remote Site Access platform in place today, it is important to begin researching solutions so you can take advantage of this shift in 2021. To learn more about what to look for in a eISF (eRegulatory) vendor, this checklist is a great place to start.

About the Author:

Jeff Pool is VP of Revenue at Florence, the leading eISF + Remote Site Access platform in clinical trials with more than 10,000 study sites in 44 countries connected to the platform. Jeff works with both research sites and sponsors/CROs to create collaborative solutions that accelerate research.